The Next Supreme Court Cases To Shape Patent Law

Law360, New York (January 1, 2014, 3:16 PM EST) -- The U.S. Supreme Court’s patent docket has continued its steady rise over the past few terms. The court last term decided Association for Molecular Pathology v. Myriad Genetics Inc. (naturally occurring DNA patent-ineligible) and Bowman v. Monsanto Co. (exhaustion inapplicable to reproduction of patented seed), and recently heard argument in Medtronic Inc. v. Boston Scientific Corp. over the burden of proof in a patent licensee’s declaratory judgment action. The court has two more patent cases on its docket involving attorney fees, and recently granted certiorari in...
To view the full article, register now.